Aim: Describe the characteristics of providers ordering, patients receiving, and clinical impact of a psychotropic pharmacogenetic test on veteran care. Patients & methods: Observational cohort study linking veterans' laboratory results to electronic health record data. Changes in psychotropic medication prescribing were measured as a function of test results. Results: A total of 38 providers tested 181 veterans between 10/6/2014 and 2/1/2018. Prescriptions for medications with severe gene-drug interactions decreased; however, 11 such medications were used after testing. For 43 patients, documentation of the results was missing. Conclusion: Most prescribing decisions were congruent with test results, but in a nontrivial number of cases, prescribers appeared not to act on the results. Poor result documentation impeded the potential of results to inform clinical care.
CITATION STYLE
Hull, L. E., Chanfreau-Coffinier, C., Tuteja, S., Berlowitz, D., Lehmann, L. S., Oslin, D. W., … Lynch, J. A. (2019). Early adoption of pharmacogenetic testing for veterans prescribed psychotropic medications. Pharmacogenomics, 20(11), 781–789. https://doi.org/10.2217/pgs-2019-0065
Mendeley helps you to discover research relevant for your work.